ask="11.86"
ask_size="1700"
average_daily_volume="1973210"
bid="11.61"
bid_size="1000"
book_value="-0.09"
change="-0.06"
change_from_200_day_moving_average="1.36"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-3.59"
change_From_52_week_low="4.89"
change_in_percent="-0.50%"
close="11.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.74"
ex_dividend_date="N/A"
float_shares="94960000"
high="12.25"
high_52_weeks="15.44"
last_trade_date="1/12/2017"
last_trade_price="11.85"
last_trade_size="117"
last_trade_time="3:59pm"
low="11.34"
low_52_weeks="6.96"
market_capitalization="1.52B"
moving_average_200_day="10.49"
moving_average_50_day="11.44"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="11.71"
pe_ratio="N/A"
peg_ratio="-0.31"
percent_change_from_200_day_moving_average="+12.93%"
percent_change_from_50_day_moving_average="+3.63%"
percent_change_from_52_week_high="-23.25%"
percent_change_from_52_week_low="+70.26%"
previous_close="11.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.54"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="15.05"
stock_exchange="NMS"
symbol="HALO"
volume="1946623"
weeks_range_52="6.96 - 15.44"
